Emanuele Miraglia Del Giudice Selected Research

Cannabinoid Receptors (Cannabinoid Receptor)

1/2016	Cannabinoid Receptor 2 as Antiobesity Target: Inflammation, Fat Storage, and Browning Modulation.
1/2014	Cannabinoid receptor 2-63 QQ variant is associated with persistently normal aminotransferase serum levels in chronic hepatitis C.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Emanuele Miraglia Del Giudice Research Topics

Disease

5	Obesity 01/2020 - 08/2008
4	Pediatric Obesity 01/2016 - 04/2007
4	Insulin Resistance 09/2014 - 11/2006
3	Hypertension (High Blood Pressure) 08/2014 - 08/2008
2	Overweight 01/2020 - 08/2014
2	Weight Loss (Weight Reduction) 05/2010 - 04/2007
1	Familial Mediterranean Fever (Periodic Disease) 06/2021
1	Purpura 01/2021
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2020
1	Weight Gain 01/2020
1	Brain Diseases (Brain Disorder) 09/2018
1	Non-alcoholic Fatty Liver Disease 01/2018
1	Hypothyroidism 08/2017
1	Hyperplasia 01/2016
1	Hypertrophy 01/2016
1	Inflammation (Inflammations) 01/2016
1	Iron Deficiencies 11/2015
1	Cognitive Dysfunction 11/2015
1	Liver Cirrhosis (Hepatic Cirrhosis) 09/2014
1	Infections 09/2014
1	Disease Progression 09/2014
1	Hepatitis B 09/2014
1	Fatty Liver 04/2014
1	Chronic Hepatitis C 01/2014
1	Arnold-Chiari Malformation (Arnold-Chiari Syndrome) 02/2013
1	Rubinstein-Taybi Syndrome (Syndrome, Rubinstein-Taybi) 02/2013
1	Hypertriglyceridemia 01/2013
1	Glucose Intolerance 01/2009
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2009
1	Seizures (Absence Seizure) 03/2006
1	Body Weight (Weight, Body) 10/2004
1	Channelopathies 06/2004
1	Hyperekplexia 06/2004

Drug/Important Bio-Agent (IBA)

3	Glucose (Dextrose)FDA LinkGeneric 08/2014 - 01/2009
2	Insulin (Novolin)FDA Link 01/2020 - 11/2006
2	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 08/2017 - 05/2010
2	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2016 - 01/2014
1	Colchicine FDA LinkGeneric 06/2021
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2021
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2021
1	antiarrhythmic peptide (AAP)IBA 01/2020
1	AcyltransferasesIBA 01/2018
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	Adenosine Diphosphate (ADP)IBA 01/2016
1	CB2 Cannabinoid ReceptorIBA 01/2016
1	1,1-dimethylbutyl-1-deoxy-Delta(9)-THCIBA 01/2016
1	IronIBA 11/2015
1	HepcidinsIBA 11/2015
1	RNA (Ribonucleic Acid)IBA 09/2014
1	Phospholipases (Phospholipase)IBA 09/2014
1	HDL-triglycerideIBA 08/2014
1	glucokinase regulatory proteinIBA 04/2014
1	Transaminases (Aminotransferases)IBA 01/2014
1	Carrier Proteins (Binding Protein)IBA 02/2013
1	Growth Hormone (Somatotropin)IBA 02/2013
1	HDL CholesterolIBA 01/2013
1	ectonucleotide pyrophosphatase phosphodiesterase 1IBA 01/2009
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2009
1	nucleotide pyrophosphataseIBA 01/2009
1	Peptide YYIBA 08/2008
1	Type 3 Melanocortin ReceptorIBA 04/2007
1	Chloride Channels (Chloride Channel)IBA 03/2006
1	SodiumIBA 03/2006
1	PotassiumIBA 03/2006
1	Ion Channels (Ion Channel)IBA 03/2006
1	ChloridesIBA 03/2006
1	GlucocorticoidsIBA 10/2004
1	Dopamine (Intropin)FDA LinkGeneric 10/2004
1	Glycine Receptors (Glycine Receptor)IBA 06/2004

Therapy/Procedure

2	Therapeutics 01/2020 - 11/2015
1	Induced Hypothermia 09/2018